메뉴 건너뛰기




Volumn 188, Issue 5, 2012, Pages 2136-2145

HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; CAFFEINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; HLA A ANTIGEN; HLA B ANTIGEN; NATURAL KILLER CELL RECEPTOR NKG2D; NEU DIFFERENTIATION FACTOR; NEUREGULIN 1BETA; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

EID: 84857477795     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102237     Document Type: Article
Times cited : (55)

References (51)
  • 1
    • 0033618504 scopus 로고    scopus 로고
    • Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA
    • Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA. Science 285: 727-729.
    • Science , vol.285 , pp. 727-729
    • Bauer, S.1    Groh, V.2    Wu, J.3    Steinle, A.4    Phillips, J.H.5    Lanier, L.L.6    Spies, T.7
  • 3
    • 29444455376 scopus 로고    scopus 로고
    • NKG2D in NK and T cell-mediated immunity
    • DOI 10.1007/s10875-005-8786-4
    • Ogasawara, K., and L. L. Lanier. 2005. NKG2D in NK and T cell-mediated immunity. J. Clin. Immunol. 25: 534-540. (Pubitemid 43011745)
    • (2005) Journal of Clinical Immunology , vol.25 , Issue.6 , pp. 534-540
    • Ogasawara, K.1    Lanier, L.L.2
  • 4
    • 0029861713 scopus 로고    scopus 로고
    • Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
    • Groh, V., S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93: 12445-12450.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 12445-12450
    • Groh, V.1    Bahram, S.2    Bauer, S.3    Herman, A.4    Beauchamp, M.5    Spies, T.6
  • 5
    • 24144443517 scopus 로고    scopus 로고
    • The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
    • DOI 10.1038/nature03884
    • Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190. (Pubitemid 41232299)
    • (2005) Nature , vol.436 , Issue.7054 , pp. 1186-1190
    • Gasser, S.1    Orsulic, S.2    Brown, E.J.3    Raulet, D.H.4
  • 7
    • 33750694590 scopus 로고    scopus 로고
    • Activation, coactivation, and costimulation of resting human natural killer cells
    • DOI 10.1111/j.1600-065X.2006.00457.x
    • Bryceson, Y. T., M. E. March, H. G. Ljunggren, and E. O. Long. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214: 73-91. (Pubitemid 44707903)
    • (2006) Immunological Reviews , vol.214 , Issue.1 , pp. 73-91
    • Bryceson, Y.T.1    March, M.E.2    Ljunggren, H.-G.3    Long, E.O.4
  • 8
    • 0035949563 scopus 로고    scopus 로고
    • Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
    • DOI 10.1073/pnas.201238598
    • Cerwenka, A., J. L. Baron, and L. L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98: 11521-11526. (Pubitemid 32928761)
    • (2001) Proceedings of the National Academy of Sciences of the United States of America , vol.98 , Issue.20 , pp. 11521-11526
    • Cerwenka, A.1    Baron, J.L.2    Lanier, L.L.3
  • 9
    • 2342591455 scopus 로고    scopus 로고
    • The discovery of receptor tyrosine kinases: Targets for cancer therapy
    • Gschwind, A., O. M. Fischer, and A. Ullrich. 2004. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 4: 361-370. (Pubitemid 38579482)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.5 , pp. 361-370
    • Gschwind, A.1    Fischer, O.M.2    Ullrich, A.3
  • 13
    • 0029814271 scopus 로고    scopus 로고
    • A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
    • Tzahar, E., H. Waterman, X. Chen, G. Levkowitz, D. Karunagaran, S. Lavi, B. J. Ratzkin, and Y. Yarden. 1996. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/ neuregulin and epidermal growth factor. Mol. Cell. Biol. 16: 5276-5287. (Pubitemid 26315047)
    • (1996) Molecular and Cellular Biology , vol.16 , Issue.10 , pp. 5276-5287
    • Tzahar, E.1    Waterman, H.2    Chen, X.3    Levkowitz, G.4    Karunagaran, D.5    Lavi, S.6    Ratzkin, B.J.7    Yarden, Y.8
  • 16
    • 18344390418 scopus 로고    scopus 로고
    • ERBB receptors and cancer: The complexity of targeted inhibitors
    • DOI 10.1038/nrc1609
    • Hynes, N. E., and H. A. Lane. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5: 341-354. (Pubitemid 40637826)
    • (2005) Nature Reviews Cancer , vol.5 , Issue.5 , pp. 341-354
    • Hynes, N.E.1    Lane, H.A.2
  • 18
    • 16244409820 scopus 로고    scopus 로고
    • Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
    • DOI 10.1038/sj.onc.1208381
    • Sithanandam, G., L. W. Fornwald, J. Fields, and L. M. Anderson. 2005. Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549. Oncogene 24: 1847-1859. (Pubitemid 40462787)
    • (2005) Oncogene , vol.24 , Issue.11 , pp. 1847-1859
    • Sithanandam, G.1    Fornwald, L.W.2    Fields, J.3    Anderson, L.M.4
  • 20
    • 0038575385 scopus 로고    scopus 로고
    • Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer
    • Witton, C. J., J. R. Reeves, J. J. Going, T. G. Cooke, and J. M. Bartlett. 2003. Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J. Pathol. 200: 290-297.
    • (2003) J. Pathol. , vol.200 , pp. 290-297
    • Witton, C.J.1    Reeves, J.R.2    Going, J.J.3    Cooke, T.G.4    Bartlett, J.M.5
  • 21
    • 0031406620 scopus 로고    scopus 로고
    • c-erbB-3 protein expression in ductal carcinoma in situ of the breast
    • DOI 10.1016/S0959-8049(97)00244-X, PII S095980499700244X
    • Bobrow, L. G., R. R. Millis, L. C. Happerfield, and W. J. Gullick. 1997. c-erbB-3 protein expression in ductal carcinoma in situ of the breast. Eur. J. Cancer 33: 1846-1850. (Pubitemid 28129215)
    • (1997) European Journal of Cancer , vol.33 , Issue.11 , pp. 1846-1850
    • Bobrow, L.G.1    Millis, R.R.2    Happerfield, L.C.3    Gullick, W.J.4
  • 23
    • 0028169757 scopus 로고
    • C-erbB-3 protein expression in human breast cancer: Comparison with other tumour variables and survival
    • Quinn, C. M., J. L. Ostrowski, S. A. Lane, D. P. Loney, J. Teasdale, and F. A. Benson. 1994. c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathology 25: 247-252.
    • (1994) Histopathology , vol.25 , pp. 247-252
    • Quinn, C.M.1    Ostrowski, J.L.2    Lane, S.A.3    Loney, D.P.4    Teasdale, J.5    Benson, F.A.6
  • 25
    • 79952041937 scopus 로고    scopus 로고
    • Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: A 4-year follow-up of a randomised controlled trial
    • Herceptin Adjuvant (HERA) Trial Study Team
    • Gianni, L., U. Dafni, R. D. Gelber, E. Azambuja, S. Muehlbauer, A. Goldhirsch, M. Untch, I. Smith, J. Baselga, C. Jackisch, et al; Herceptin Adjuvant (HERA) Trial Study Team. 2011. Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol. 12: 236-244.
    • (2011) Lancet Oncol. , vol.12 , pp. 236-244
    • Gianni, L.1    Dafni, U.2    Gelber, R.D.3    Azambuja, E.4    Muehlbauer, S.5    Goldhirsch, A.6    Untch, M.7    Smith, I.8    Baselga, J.9    Jackisch, C.10
  • 26
    • 67649472398 scopus 로고    scopus 로고
    • Novel anticancer targets: Revisiting ERBB2 and discovering ERBB3
    • Baselga, J., and S. M. Swain. 2009. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 9: 463-475.
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 463-475
    • Baselga, J.1    Swain, S.M.2
  • 28
    • 0031870766 scopus 로고    scopus 로고
    • Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice
    • DOI 10.1002/(SICI)1097-0215(19980911)77:6<937::AID-IJC24>3.0.CO;2-X
    • Lollini, P. L., G. Nicoletti, L. Landuzzi, C. De Giovanni, I. Rossi, E. Di Carlo, P. Musiani, W. J. Muller, and P. Nanni. 1998. Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice. Int. J. Cancer 77: 937-941. (Pubitemid 28378147)
    • (1998) International Journal of Cancer , vol.77 , Issue.6 , pp. 937-941
    • Lollini, P.-L.1    Nicoletti, G.2    Landuzzi, L.3    De Giovanni, C.4    Rossi, I.5    Di, C.E.6    Musiani, P.7    Muller, W.J.8    Nanni, P.9
  • 29
    • 1642535582 scopus 로고    scopus 로고
    • HER-2/neu-Mediated Regulation of Components of the MHC Class I Antigen-Processing Pathway
    • DOI 10.1158/0008-5472.CAN-2522-2
    • Herrmann, F., H. A. Lehr, I. Drexler, G. Sutter, J. Hengstler, U. Wollscheid, and B. Seliger. 2004. HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway. Cancer Res. 64: 215-220. (Pubitemid 38114101)
    • (2004) Cancer Research , vol.64 , Issue.1 , pp. 215-220
    • Herrmann, F.1    Lehr, H.-A.2    Drexler, I.3    Sutter, G.4    Hengstler, J.5    Wollscheid, U.6    Seliger, B.7
  • 30
    • 0344825125 scopus 로고    scopus 로고
    • Small interfering RNA (siRNA) inhibits the expression of the Her2/Neu gene, upregulates HLA class I and induces apoptosis of Her2/Neu positive tumor cell lines
    • DOI 10.1002/ijc.11497
    • Choudhury, A., J. Charo, S. K. Parapuram, R. C. Hunt, D. M. Hunt, B. Seliger, and R. Kiessling. 2004. Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/ neu positive tumor cell lines. Int. J. Cancer 108: 71-77. (Pubitemid 37444446)
    • (2004) International Journal of Cancer , vol.108 , Issue.1 , pp. 71-77
    • Choudhury, A.1    Charo, J.2    Parapuram, S.K.3    Hunt, R.C.4    Hunt, D.M.5    Seliger, B.6    Kiessling, R.7
  • 31
    • 61349186956 scopus 로고    scopus 로고
    • HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
    • Vertuani, S., C. Triulzi, A. K. Roos, J. Charo, H. Norell, F. Lemonnier, P. Pisa, B. Seliger, and R. Kiessling. 2009. HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice. Cancer Immunol. Immunother. 58: 653-664.
    • (2009) Cancer Immunol. Immunother. , vol.58 , pp. 653-664
    • Vertuani, S.1    Triulzi, C.2    Roos, A.K.3    Charo, J.4    Norell, H.5    Lemonnier, F.6    Pisa, P.7    Seliger, B.8    Kiessling, R.9
  • 33
    • 0022616253 scopus 로고
    • Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
    • Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678. (Pubitemid 16119452)
    • (1986) Nature , vol.319 , Issue.6055 , pp. 675-678
    • Karre, K.1    Ljunggren, H.G.2    Piontek, G.3    Kiessling, R.4
  • 34
    • 77956642196 scopus 로고    scopus 로고
    • Natural killer cell education and tolerance
    • Orr, M. T., and L. L. Lanier. 2010. Natural killer cell education and tolerance. Cell 142: 847-856.
    • (2010) Cell , vol.142 , pp. 847-856
    • Orr, M.T.1    Lanier, L.L.2
  • 35
    • 0344745168 scopus 로고
    • Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity
    • DOI 10.1073/pnas.83.15.5620
    • Torsteinsdottir, S., M. G. Masucci, B. Ehlin-Henriksson, C. Brautbar, H. Ben Bassat, G. Klein, and E. Klein. 1986. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc. Natl. Acad. Sci. USA 83: 5620-5624. (Pubitemid 16001269)
    • (1986) Proceedings of the National Academy of Sciences of the United States of America , vol.83 , Issue.15 , pp. 5620-5624
    • Torsteinsdottir, S.1    Masucci, M.G.2    Ehlin-Henriksson, B.3
  • 36
    • 0037068741 scopus 로고    scopus 로고
    • Anti-tumor activity of GW572016: A dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways
    • Xia, W., R. J. Mullin, B. R. Keith, L. H. Liu, H. Ma, D. W. Rusnak, G. Owens, K. J. Alligood, and N. L. Spector. 2002. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene 21: 6255-6263.
    • (2002) Oncogene , vol.21 , pp. 6255-6263
    • Xia, W.1    Mullin, R.J.2    Keith, B.R.3    Liu, L.H.4    Ma, H.5    Rusnak, D.W.6    Owens, G.7    Alligood, K.J.8    Spector, N.L.9
  • 37
    • 16344363218 scopus 로고    scopus 로고
    • Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth
    • DOI 10.1158/1078-0432.CCR-04-1158
    • Gregory, C. W., Y. E. Whang, W. McCall, X. Fei, Y. Liu, L. A. Ponguta, F. S. French, E. M. Wilson, and H. S. Earp, III. 2005. Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth. Clin. Cancer Res. 11: 1704-1712. (Pubitemid 40471831)
    • (2005) Clinical Cancer Research , vol.11 , Issue.5 , pp. 1704-1712
    • Gregory, C.W.1    Whang, Y.E.2    McCall, W.3    Fei, X.4    Liu, Y.5    Ponguta, L.A.6    French, F.S.7    Wilson, E.M.8    Earp III, H.S.9
  • 38
    • 0028170210 scopus 로고
    • A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran- 4-one (LY294002)
    • Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran- 4-one (LY294002). J. Biol. Chem. 269: 5241-5248.
    • (1994) J. Biol. Chem. , vol.269 , pp. 5241-5248
    • Vlahos, C.J.1    Matter, W.F.2    Hui, K.Y.3    Brown, R.F.4
  • 39
    • 0029034774 scopus 로고
    • Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
    • Pang, L., T. Sawada, S. J. Decker, and A. R. Saltiel. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270: 13585-13588.
    • (1995) J. Biol. Chem. , vol.270 , pp. 13585-13588
    • Pang, L.1    Sawada, T.2    Decker, S.J.3    Saltiel, A.R.4
  • 41
    • 0021151237 scopus 로고
    • Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II
    • Tewey, K. M., T. C. Rowe, L. Yang, B. D. Halligan, and L. F. Liu. 1984. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466-468.
    • (1984) Science , vol.226 , pp. 466-468
    • Tewey, K.M.1    Rowe, T.C.2    Yang, L.3    Halligan, B.D.4    Liu, L.F.5
  • 42
    • 11144234525 scopus 로고    scopus 로고
    • Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species
    • DOI 10.1074/jbc.M406879200
    • Kurz, E. U., P. Douglas, and S. P. Lees-Miller. 2004. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem. 279: 53272-53281. (Pubitemid 40051831)
    • (2004) Journal of Biological Chemistry , vol.279 , Issue.51 , pp. 53272-53281
    • Kurz, E.U.1    Douglas, P.2    Lees-Miller, S.P.3
  • 43
    • 65349131915 scopus 로고    scopus 로고
    • ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
    • Soriani, A., A. Zingoni, C. Cerboni, M. L. Iannitto, M. R. Ricciardi, V. Di Gialleonardo, M. Cippitelli, C. Fionda, M. T. Petrucci, A. Guarini, et al. 2009. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
    • (2009) Blood , vol.113 , pp. 3503-3511
    • Soriani, A.1    Zingoni, A.2    Cerboni, C.3    Iannitto, M.L.4    Ricciardi, M.R.5    Di Gialleonardo, V.6    Cippitelli, M.7    Fionda, C.8    Petrucci, M.T.9    Guarini, A.10
  • 44
  • 45
    • 0032513388 scopus 로고    scopus 로고
    • Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells
    • DOI 10.1126/science.279.5357.1737
    • Groh, V., A. Steinle, S. Bauer, and T. Spies. 1998. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279: 1737-1740. (Pubitemid 28164472)
    • (1998) Science , vol.279 , Issue.5357 , pp. 1737-1740
    • Groh, V.1    Steinle, A.2    Bauer, S.3    Spies, T.4
  • 46
  • 47
    • 33846245583 scopus 로고    scopus 로고
    • Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D
    • Venkataraman, G. M., D. Suciu, V. Groh, J. M. Boss, and T. Spies. 2007. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178: 961-969. (Pubitemid 46095169)
    • (2007) Journal of Immunology , vol.178 , Issue.2 , pp. 961-969
    • Venkataraman, G.M.1    Suciu, D.2    Groh, V.3    Boss, J.M.4    Spies, T.5
  • 51
    • 79958856696 scopus 로고    scopus 로고
    • Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytoxicity of EGFR- And HER2- overexpressing esophageal cancer cell lines
    • Mimura, K., K. Kono, T. Maruyama, M. Watanabe, S. Izawa, S. Shiba, Y. Mizukami, Y. Kawaguchi, M. Inoue, T. Kono, et al. 2011. Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytoxicity of EGFR- and HER2- overexpressing esophageal cancer cell lines. Int. J. Cancer 129: 2408-2416.
    • (2011) Int. J. Cancer , vol.129 , pp. 2408-2416
    • Mimura, K.1    Kono, K.2    Maruyama, T.3    Watanabe, M.4    Izawa, S.5    Shiba, S.6    Mizukami, Y.7    Kawaguchi, Y.8    Inoue, M.9    Kono, T.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.